Voronoi보로노이

Voronoi310210· Biotech & PharmaInitiation

Voronoi: Deep Losses and Minimal Revenue Meet a Share Price Well Below Its 52-Week High

Voronoi, a KOSDAQ-listed biotech, closed at ₩125,900 on 2026-10-12 for a market cap of about ₩2.3T, after falling 25.0% over one year. Filed statements show trailing revenue of ₩4.2B against an operating loss of ₩81.0B, so the valuation rests on factors the financials do not capture.

Oct 13, 20260 views